Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

348 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Levovist ultrasonographic contrast agent on the diagnosis and management of hypertensive patients with suspected renal artery stenosis: a Canadian multicentre pilot study.
Lacourcière Y, Lévesque J, Onrot JM, Wilson SR, Szaky E, Thibodeau M, Vasilevsky ML, Dashefsky SM, Allan DR, Lafortune M, Vendeville B, Zaleski WM, Pagé DE, D'Onofrio F. Lacourcière Y, et al. Can Assoc Radiol J. 2002 Oct;53(4):219-27. Can Assoc Radiol J. 2002. PMID: 12391928 Clinical Trial.
Integrative analysis of transcriptomic and immunoproteomic data reveals stress response mechanisms in Listeria monocytogenes.
D'Onofrio F, Butler F, Krasteva I, Schirone M, Iannetti L, Torresi M, Di Pancrazio C, Perletta F, Maggetti M, Marcacci M, Ancora M, Di Domenico M, Di Lollo V, Cammà C, Tittarelli M, Sacchini F, Pomilio F, D'Alterio N, Luciani M. D'Onofrio F, et al. Heliyon. 2024 Oct 24;10(21):e39832. doi: 10.1016/j.heliyon.2024.e39832. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39524754 Free PMC article.
Adaptive strategies of Listeria monocytogenes: An in-depth analysis of the virulent strain involved in an outbreak in Italy through quantitative proteomics.
Luciani M, Krasteva I, Schirone M, D'Onofrio F, Iannetti L, Torresi M, Di Pancrazio C, Perletta F, Valentinuzzi S, Tittarelli M, Pomilio F, D'Alterio N, Paparella A, Del Boccio P. Luciani M, et al. Among authors: d onofrio f. Int J Food Microbiol. 2025 Jan 16;427:110951. doi: 10.1016/j.ijfoodmicro.2024.110951. Epub 2024 Oct 28. Int J Food Microbiol. 2025. PMID: 39486093 Free article.
Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study.
Barbanti P, Egeo G, Proietti S, d'Onofrio F, Aurilia C, Finocchi C, Di Clemente L, Zucco M, Doretti A, Messina S, Autunno M, Ranieri A, Carnevale A, Colombo B, Filippi M, Tasillo M, Rinalduzzi S, Querzani P, Sette G, Forino L, Zoroddu F, Robotti M, Valenza A, Camarda C, Borrello L, Aguggia M, Viticchi G, Tomino C, Fiorentini G, Orlando B, Bonassi S, Torelli P; Italian Migraine Registry study group. Barbanti P, et al. Among authors: d onofrio f. Neurol Ther. 2024 Oct;13(5):1505-1506. doi: 10.1007/s40120-024-00648-z. Neurol Ther. 2024. PMID: 39106033 Free PMC article. No abstract available.
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE-The First Italian Multicenter, Prospective, Real-Life Study.
Barbanti P, Orlando B, Egeo G, d'Onofrio F, Doretti A, Messina S, Autunno M, Messina R, Filippi M, Fiorentini G, Rotondi C, Bonassi S, Aurilia C. Barbanti P, et al. Among authors: d onofrio f. Brain Sci. 2024 Jun 30;14(7):672. doi: 10.3390/brainsci14070672. Brain Sci. 2024. PMID: 39061413 Free PMC article.
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world.
Caronna E, Gallardo VJ, Egeo G, Vázquez MM, Castellanos CN, Membrilla JA, Vaghi G, Rodríguez-Montolio J, Fabregat Fabra N, Sánchez-Caballero F, Jaimes Sánchez A, Muñoz-Vendrell A, Oliveira R, Gárate G, González-Osorio Y, Guisado-Alonso D, Ornello R, Thunstedt C, Fernández-Lázaro I, Torres-Ferrús M, Alpuente A, Torelli P, Aurilia C, Pére RL, Castrillo MJR, Icco R, Sances G, Broadhurst S, Ong HC, García AG, Campoy S, Sanahuja J, Cabral G, Beltrán Blasco I, Waliszewska-Prosół M, Pereira L, Layos-Romero A, Luzeiro I, Dorado L, Álvarez Escudero MR, May A, López-Bravo A, Martins IP, Sundal C, Irimia P, Lozano Ros A, Gago-Veiga AB, Juanes FV, Ruscheweyh R, Sacco S, Cuadrado-Godia E, García-Azorín D, Pascual J, Gil-Gouveia R, Huerta-Villanueva M, Rodriguez-Vico J, Viguera Romero J, Obach V, Santos-Lasaosa S, Ghadiri-Sani M, Tassorelli C, Díaz-de-Terán J, Díaz Insa S, Oria CG, Barbanti P, Pozo-Rosich P; EUREkA study group. Caronna E, et al. J Neurol Neurosurg Psychiatry. 2024 Sep 17;95(10):927-937. doi: 10.1136/jnnp-2023-333295. J Neurol Neurosurg Psychiatry. 2024. PMID: 38777579
348 results